rs41306576
Variant names:
Variant summary
Our verdict is Benign. The variant received -17 ACMG points: 0P and 17B. BP4_StrongBP6_Very_StrongBP7BS2
The NM_007365.3(PADI2):c.1413C>T(p.His471His) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.005 in 1,614,014 control chromosomes in the GnomAD database, including 30 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0035 ( 3 hom., cov: 32)
Exomes 𝑓: 0.0052 ( 27 hom. )
Consequence
PADI2
NM_007365.3 synonymous
NM_007365.3 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.311
Publications
0 publications found
Genes affected
PADI2 (HGNC:18341): (peptidyl arginine deiminase 2) This gene encodes a member of the peptidyl arginine deiminase family of enzymes, which catalyze the post-translational deimination of proteins by converting arginine residues into citrullines in the presence of calcium ions. The family members have distinct substrate specificities and tissue-specific expression patterns. The type II enzyme is the most widely expressed family member. Known substrates for this enzyme include myelin basic protein in the central nervous system and vimentin in skeletal muscle and macrophages. This enzyme is thought to play a role in the onset and progression of neurodegenerative human disorders, including Alzheimer disease and multiple sclerosis, and it has also been implicated in glaucoma pathogenesis. This gene exists in a cluster with four other paralogous genes. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -17 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.53).
BP6
Variant 1-17075721-G-A is Benign according to our data. Variant chr1-17075721-G-A is described in ClinVar as [Benign]. Clinvar id is 773390.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.311 with no splicing effect.
BS2
High Homozygotes in GnomAd4 at 3 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PADI2 | NM_007365.3 | c.1413C>T | p.His471His | synonymous_variant | Exon 12 of 16 | ENST00000375486.9 | NP_031391.2 | |
PADI2 | XM_017000148.3 | c.468C>T | p.His156His | synonymous_variant | Exon 4 of 8 | XP_016855637.1 | ||
PADI2 | XM_047442975.1 | c.*67C>T | 3_prime_UTR_variant | Exon 11 of 11 | XP_047298931.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00350 AC: 532AN: 152180Hom.: 3 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
532
AN:
152180
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.00324 AC: 814AN: 251186 AF XY: 0.00334 show subpopulations
GnomAD2 exomes
AF:
AC:
814
AN:
251186
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00516 AC: 7537AN: 1461716Hom.: 27 Cov.: 39 AF XY: 0.00499 AC XY: 3631AN XY: 727170 show subpopulations
GnomAD4 exome
AF:
AC:
7537
AN:
1461716
Hom.:
Cov.:
39
AF XY:
AC XY:
3631
AN XY:
727170
show subpopulations
African (AFR)
AF:
AC:
24
AN:
33478
American (AMR)
AF:
AC:
62
AN:
44686
Ashkenazi Jewish (ASJ)
AF:
AC:
3
AN:
26130
East Asian (EAS)
AF:
AC:
2
AN:
39690
South Asian (SAS)
AF:
AC:
303
AN:
86238
European-Finnish (FIN)
AF:
AC:
111
AN:
53412
Middle Eastern (MID)
AF:
AC:
12
AN:
5766
European-Non Finnish (NFE)
AF:
AC:
6728
AN:
1111924
Other (OTH)
AF:
AC:
292
AN:
60392
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.480
Heterozygous variant carriers
0
379
757
1136
1514
1893
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome AF: 0.00350 AC: 533AN: 152298Hom.: 3 Cov.: 32 AF XY: 0.00334 AC XY: 249AN XY: 74464 show subpopulations
GnomAD4 genome
AF:
AC:
533
AN:
152298
Hom.:
Cov.:
32
AF XY:
AC XY:
249
AN XY:
74464
show subpopulations
African (AFR)
AF:
AC:
47
AN:
41550
American (AMR)
AF:
AC:
16
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3472
East Asian (EAS)
AF:
AC:
2
AN:
5184
South Asian (SAS)
AF:
AC:
17
AN:
4820
European-Finnish (FIN)
AF:
AC:
20
AN:
10616
Middle Eastern (MID)
AF:
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
AC:
421
AN:
68038
Other (OTH)
AF:
AC:
7
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
27
55
82
110
137
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
9
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Dec 31, 2019
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.